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We report a case of a 70-year-oldman, with a status after aortic valve replacement, who presented withmelena and hypotension. On
physical examination, he was hypotensive, but he responded to resuscitation. Esophagogastroduodenoscopy revealed a submucosal
mass in the gastric fundus. Imaging of the chest, abdomen, and pelvis showed no evidence of local or distant metastasis. He
underwent a partial diaphragmatic resection, gastrectomy, lymphadenectomy, and Roux-en-Y esophagojejunostomy. Pathology
showed a gastric squamous cell carcinoma (SCC) invading the diaphragm, with negative margins of resection, and one positive
perigastric lymph node. He received chemoradiation, but the patient expired 27 months after surgery.
1. Introduction
Primary gastric squamous cell carcinoma (PGSCC) is an
extremely rare neoplasm. It accounts for 0.04–0.07% of all
gastric carcinomas [1–5], with fewer than one hundred cases
having been reported in the literature [6]. The pathogenesis
of this tumor remains unclear; most of the cases have a late
diagnosis.The optimal treatment strategy is controversial and
the prognosis is poor. Although the incidence of gastric can-
cer in Japan is much higher than that in Western countries,
primary gastric SCC is still rare [1, 2]. We report a case
of advanced PGSCC, who presented with melena and an
ulcerated submucosal mass in the fundus of the stomach.The
patient underwent radical resection and received adjuvant
chemoradiation therapy. The disease progressed on chemo-
therapy and he expired 27 months after surgery.
2. Case Report
We report a case of a 70-year-old white male, with a status
after uncomplicated aortic valve replacement for severe aor-
tic stenosis, who presented with melena and hypotension,
returning to the hospital the same day of discharge. He repo-
rted a 15-pound weight loss over a few months. His past
medical history was significant for a 60-pack-year smoking
history and severe aortic stenosis. On physical examination,
he was pale, tachycardic, and hypotensive, but he responded
well to resuscitation. Esophagogastroduodenoscopy (EGD)
revealed a seven-centimeter ulcerated submucosal mass in
the fundus of the stomach without active bleeding (Figure 1),
and biopsy was not attempted. Imaging of the chest and
abdomen revealed a 7 × 4 cmmass in the gastric fundus with
no evidence of locoregional extension or distant metastasis
(Figure 2). He was taken to the operating room and it was
found that the mass was locally invading the left hemidi-
aphragm. He underwent a partial left diaphragmatic resec-
tion, total gastrectomy, D1A lymphadenectomy, reconstruc-
tion with Roux-en-Y esophagojejunostomy, and a feeding
tube jejunostomy. Histological and immunohistochemical
analysis revealed an infiltrating moderately differentiated
gastric squamous cell carcinoma (SCC) with direct invasion
to the adjacent diaphragm striated muscle, with free margin
resection, and one perigastric lymph node was positive for
metastatic disease for a T4, N1, and M0 disease. Immunohis-
tochemistrywas positive for cytokeratin 5/6, p63 andnegative
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Figure 1: Esophagogastroduodenoscopy (EGD) showing an ulcer-
ated submucosal mass in the fundus of the stomach (white arrow).
Figure 2: Computerized axial tomography scan with IV and PO
contrast showing a mass in the gastric fundus (red arrow).
for CD117, CK20, and p16.Three months after surgery, he was
started on adjuvant radiation therapy and chemotherapywith
capecitabine and oxaliplatin. He developed recurrent disease
in the peritoneum and multiple liver metastases were found
on positron emission tomography scan (PET). He received
sorafenib, but he presented severe fatigue and the dose was
decreased and eventually stopped. Carboplatin plus irinote-
can was started 16 months after surgery due to progression
of liver metastases. Twenty months after surgery, imaging
showed progression of disease and 5-fluorouracil and gem-
citabine were started with no response. Subsequently, he had
progression of disease and expired 27 months after surgery.
3. Pathology
The surgical specimen was composed of a total gastrectomy
with partial resection of adherent diaphragm. There was a
submucosal tan/white softmassmeasuring 4.0 × 3.5 × 3.5 cm,
with focal necrosis, located at the fundus. The tumor did not
extend to the surgical specimen margins. Examination of the
gastric and duodenal tissue revealed no further tumor mass.
Histologically, the tumor showed moderately differentiated
squamous cells with keratinization andwithout glandular dif-
ferentiation (Figure 3(a)). The tumor located predominantly
in the submucosa through the serosa andwith direct invasion
to the adjacent diaphragm striated muscle (Figure 3(b)).
Lymphovascular invasion and perineural invasion were
observed adjacent to the tumor (Figures 3(c) and 3(d)),
respectively. Further immunohistochemistry showed tumor
cells with strong coexpression of CK5/6 and p63, which are
indicators of squamous cell carcinoma (Figure 4(a), dual sta–
ining), but negative for p16 (Figure 4(b)), CD117 (indicator
of gastrointestinal stromal tumor, Figure 4(c)), and CK7
(indicator of adenocarcinoma, Figure 4(d)). One perigastric
lymph node (1/13) exhibited metastatic squamous cell carci-
noma.
4. Discussion
The primary gastric squamous cell carcinoma (PGSCC) has
a worldwide incidence that is estimated to be about 0.04 to
0.07% among other gastric cancers [1–5]. It occurs mostly
in men and the male/female ratio is 5 to 1 [1, 7, 8]. It is
more prevalent in the sixth decade of life [5], and the most
common tumor location is in the upper third of the sto–
mach [1]. The gender, age at the time of presentation, and
location of our patient fit the epidemiology of this unusual
neoplasm. Ro¨rig, who described the first PGSCC case in
1895, hypothesized about basal cells in the gastric mucosa
undergoing metaplasia, transforming into squamous cells,
and later turning into SCC [9]. Since then, not much has
changed; the etiopathogenesis is still unknown, although
several theories have been proposed [5, 9, 10]. Five theories
were summarized by Straus et al. [4, 5]: (i) totipotential stem
cells in the gastric mucosa [11]; (ii) nest of ectopic squamous
epithelium in the gastric mucosa [5, 12]; (iii) squamous
metaplasia of preexisting nonneoplastic glandular epithelium
where metaplasia is induced by noxious agents as gastric acid
in the mucosa surrounding peptic ulcers [3, 7, 12], corrosive
acid ingestion [13], gastric tuberculosis [14], and so forth; (iv)
squamous differentiation in a preexisting adenocarcinoma,
supported by a report of three PGSCC tumors which were
reexamined and areas of adenocarcinoma were found. The
author suggests that stem cells turn into adenocarcinoma, and
later squamousmetaplasia occurs and finally SCC appears [7,
15]. (v) Other authors proposed origin from endothelium of
gastric vessels [16, 17]. However, it was deemed a very unlikely
origin, due to the absence of specific vascular endothelium
markers in squamous cells [6]. We particularly stand for the
squamous metaplasia of a normal gastric mucosa, because
this hypothesis is backed up by reports of PGSCC tumors
thought to have pure SCC cells and later showed to have
glandular components [4, 7, 15, 18].
The histopathological criteria for PGSCC were described
by Boswell and Helwig in 1965 [5, 7, 12], and at least one
of the following must be present to make the diagnosis: (A)
keratinized cell masses forming keratin pearls, (B) a mosaic
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Figure 3: (a) Histopathological examination showing a moderately differentiated squamous cell carcinoma with keratinization (×100).
Keratin pearl (black arrow).Mosaic cell arrangement with sharp border (red arrow). (b) Tumor invasion of the diaphragm (×100) (red arrow).
(c) Lymphovascular invasion is present (×40) (black arrow). (d) Tumor with nerve invasion (×40) (black arrow).
(a) (b)
(c) (d)
Figure 4: Tumor cells showing strong coexpression of p63 (nuclear stain, brown) and cytokeratin 5/6 (membrane stain, red) (a) and negative
expression of p16 (b), CD117 (c), and CK7 (d).
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cell arrangement, in which cell borders are sharp, (C) inter-
cellular bridges, and (D) high concentrations of sulphydryl
or disulphide bonds, indicating the presence of keratin or
prekeratin sulphydryl or disulphide bonds. We found two,
the keratin pearls and the mosaic cell arrangement with
sharp border. The intercellular bridges are usually present
in the well differentiated squamous cell carcinoma. In this
case, however, these particular features were not seen, which
indicates that cells lost tight-junction or cell-cell interaction,
with the latter being a feature of poorly differentiated tumors.
Parks published in 1967 three diagnostic criteria for
PGSCC, designed to exclude esophageal tumors and other
primary sources [5, 7, 15, 19, 20], absence of tumor in the
cardia, noninvolvement of esophagus, and no other primary
SCC elsewhere.
In our case, there was absence of tumor in the cardia,
noninvolvement of the esophagus, and the presence of other
tumors in the patient that was ruled out by further imaging.
We could label this tumor as primary gastric squamous cell
carcinoma.
Another classification is the diagnostic criteria for pri-
mary SCC of the stomach, by the Japanese Classification of
Gastric Carcinoma [21]. All tumor cells are SCC cells, with no
adenocarcinomatous components in any sections, and there
is distinct evidence that SCC arises directly from the gastric
mucosa [1, 21]. This tumor also meets these criteria, despite
the differences with the Japanese literature, which do not
exclude the cardia.
Some immunohistochemistry studies have found the dual
expression of both p63 and cytokeratin 5/6 with a specificity
of 99% and a sensitivity of 98% for squamous cell carcinoma
[22]. In this case, the tumor cells had positive immunoreac-
tivity for p63 andCK5/6, supporting the diagnosis of PGSCC.
Although chemotherapy combined with surgical resec-
tion is reported to improve survival [3, 7], currently, there is
no consensus on how to treat PGSCC. Different chemother-
apeutic regimes have been used, but there is no standard
course recommended in the literature [3, 5, 20]. Our patient
received adjuvant radiation therapy and chemotherapy with
capecitabine and oxaliplatin. He had a disease-free interval of
tenmonths, but eventually he developed tumor recurrence in
the liver and peritoneum.
Radical surgical resection is the treatment of choice when
there is no evidence of disease outside the stomach. Radical
resection for locally advanced tumors to obtain negative
margins has been suggested [5]. Our surgical procedure was a
total gastrectomywith aD1A lymphadenectomy, one perigas-
tric lymph node out of 13 was positive, which was adjacent to
the mass, “en bloc” resection with part of the left diaphragm
was necessary, and the reconstruction was done with a Roux-
en-Y esophagojejunostomy.
In conclusion, we have documented a PGSCC that meets
the current diagnostic criteria; this tumor is so uncommon
that there are no data to support radical resection, lymphad-
enectomy, and chemoradiation. In view of the fact that this
particular tumor tends to metastasize to lymph nodes and is
locally aggressive and the recurrence rate (local and distant
metastases) is high, we recommend aggressive local therapy
and adjuvant chemoradiation therapy.
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